April 20, 2018
Rose
Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler.
from MobiHealthNews https://ift.tt/2HdAXIq
April 20, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Canadian startups show off array of digital health tools- Mixed reality, extrasensory, and other trends for healthcare VR
- A realistic look at the hype of machine learning and AI
- UnitedHealthcare, Fitbit, and Castlight share secrets to workplace wellness success
- Department of Veterans Affairs looks to private developers for innovation
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment